Literature DB >> 9131516

Testosterone concentrations in men on chronic glucocorticosteroid therapy.

R C Fitzgerald1, S J Skingle, A J Crisp.   

Abstract

To determine whether free (or active) testosterone concentrations are reduced in men receiving glucocorticosteroids for chronic inflammatory diseases, 17 men (mean age 55.5 years) receiving a mean daily dose of 16.3 mg prednisolone, and 13 control patients (mean age 52.2 years) receiving no prednisolone, were studied. Serum testosterone and the testosterone/sex hormone binding globulin (SHBG) ratio were measured. The testosterone/SHBG ratio (a measure of free (active) testosterone) was significantly reduced in patients treated with prednisolone (p = 0.026), thus showing that glucocorticosteroids reduce free testosterone in male patients. This may be an important cause of glucocorticosteroid-induced osteoporosis, and suggests an additional approach to bone prophylaxis and treatment.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9131516      PMCID: PMC5420883     

Source DB:  PubMed          Journal:  J R Coll Physicians Lond        ISSN: 0035-8819


  3 in total

Review 1.  Systemic corticosteroid therapy--side effects and their management.

Authors:  R M Stanbury; E M Graham
Journal:  Br J Ophthalmol       Date:  1998-06       Impact factor: 4.638

2.  Socioeconomic conditions across life related to multiple measures of the endocrine system in older adults: Longitudinal findings from a British birth cohort study.

Authors:  David Bann; Rebecca Hardy; Rachel Cooper; Hany Lashen; Brian Keevil; Frederick C W Wu; Jeff M P Holly; Ken K Ong; Yoav Ben-Shlomo; Diana Kuh
Journal:  Soc Sci Med       Date:  2015-11-06       Impact factor: 4.634

3.  Acute anejaculation, hypogonadism, and fertility preservation in the setting of neurosarcoidosis: case report and literature review.

Authors:  Benjamin Yu; Anne L Darves-Bornoz; Robert E Brannigan; Joshua A Halpern
Journal:  F S Rep       Date:  2020-10-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.